A DOUBLE-BLIND, RANDOMIZED STUDY OF SAFE AND EFFICAACY OF ONABOTULINUMTOXINA (ONABONT-A) VERSES ORAL OXYBUTYNIN IN SCI PATIENTS WITH NDO (11-09-10-04
$904,516FY2012Department of the ArmyDOD
Baylor College Of Medicine, Houston TX
Baylor College Of Medicine, Houston TX